Skip to main content
Log in

Comparison of techniques for measurement of gelatinases/type IV collagenases: enzyme-linked immunoassays versus substrate degradation assays

  • Published:
Clinical & Experimental Metastasis Aims and scope Submit manuscript

Abstract

Radiolabeled substrate degradation assays and gelatin zymography are routinely employed to assay 72 kDa gelatinase A (MMP-2) and 92 kDa gelatinase B (MMP-9) in biological fluids. Enzyme-linked immunosorbent assays (ELISA) have recently been developed for the quantitation of these matrix metalloproteinases (MMP). In this study, we have compared ELISA to standard substrate degradation assays for measurement of MMP-2 and MMP-9 in human plasma and tumor-conditioned media. Gelatin Sepharose chromatography and gel filtration chromatography were employed as partial purification procedures for MMP-2 and MMP-9. The ELISA data for MMP-2 and MMP-9 are linear on a log:log regression curve over a wide range of MMP concentrations and are specific for the designated gelatinase, with no overlap detected with related metalloproteinases. The minimum detectable concentrations of MMP-2 and MMP-9 were approximately 0.5 ng/ml and 0.2 ng/ml, respectively, in the ELISA as compared to 4 ng/ml and 3 ng/ml, respectively, in gelatin zymography. The [3H]gelatin degradation assay required a combination of >50 ng/ml of MMP-2 and MMP-9 for detection. Although gelatin zymography was less sensitive than ELISA (primarily due to the smaller sample volume employed) and was more difficult to quantitate, this procedure offers the important advantage of being able to distinguish between latent and activated gelatinases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Brenner CA, Adler RR, Rappolee DA, Pedersin RA and Werb Z, 1989, Genes for extracellular matrix-degrading metalloproteinases and their inhibitor, TIMP, are expressed during early mammalian development.Genes and Development,3, 848–859.

    PubMed  Google Scholar 

  2. Liotta L and Stetler-Stevenson W, 1989, Metalloproteinases and malignant conversion: does correlation imply casuality?Journal of the National Cancer Institute,81, 556–557.

    PubMed  Google Scholar 

  3. Zucker S, 1988, A critical appraisal of the role of proteolytic enzymes in cancer invasion: Emphasis on tumor surface proteinases.Cancer Investigation,6, 219–231.

    PubMed  Google Scholar 

  4. Dean DD, Martel-Pelletier J, Pelletier J-P, Howell DS and Woessner JF, Jr, 1989, Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage.Journal of Clinical Investigation,84, 678–685.

    PubMed  Google Scholar 

  5. Salo T, Liotta LA and Tryggvasson K, 1983, Purification and characterization of a murine basement membrane collagen-degrading enzyme secreted by metastatic tumor cells.Journal of Biological Chemistry,258, 3058–3063.

    PubMed  Google Scholar 

  6. Nakajima M, Welch DR, Belloni PN and Nicolson GL, 1987, Degradation of basement membrane type IV collagen and lung subendothelial matrix by rat mammary adenocarcinoma cell clones of differing metastatic potentials.Cancer Research,47, 4869–4876.

    PubMed  Google Scholar 

  7. Bernhard EJ, Muschel RJ and Hughes EN, 1990, Mr 92,000 gelatinase release correlates with the metastatic phenotype in transformed rat embryo cells.Cancer Research,50, 3872–3877.

    PubMed  Google Scholar 

  8. Gabrisa S, Pozzatti R, Muschel RJ, Saffiotti U, Ballin M, Goldfarb RH, Khoury G and Liotta LA, 1987, Secretion of type IV collagenolytic protease and metastatic phenotype: Induction by transfection with C-Ha-ras but not C-Ha-ras plus Ad2-Ela.Cancer Research,47, 1523–1528.

    PubMed  Google Scholar 

  9. Takemura M, Azuma C, Kimura T, Tokugawa Y, Miki M, Ono M, Saji F and Tanizawa O, 1992, Malignant cell-specific gelatinase activity in human endometrial carcinoma.Cancer,70, 147–151.

    PubMed  Google Scholar 

  10. Yamagata S, Tanaka R, Yoshika I and Ishimizu S, 1989, Gelatinases of murine metastatic tumor cells.Biochemical and Biophysical Research Communications,158, 228–234.

    PubMed  Google Scholar 

  11. Collier IE, Wilhelm SM, Eisen AZ, Marmer BL, Grant GA, Seltzer J, Kronberger A, He C, Bauer EA and Goldberg GI, 1988, H-ras oncogene-transformed human bronchial epithelial cells (TBE) secrete a single metalloproteinase capable of degrading basement membrane collagen.Journal of Biological Chemistry,263, 6579–6587.

    PubMed  Google Scholar 

  12. Hibbs MS, Hasty KA, Seyer JM, Kang AH and Mainardi CL, 1985, Biochemical and immunological characterization of the secreted forms of human neutrophil gelatinase.Journal of Biological Chemistry,260, 2493–2500.

    PubMed  Google Scholar 

  13. Wilhelm SM, Collier IE, Marmer BL, Eisen AZ, Grant GA and Goldberg GI, 1989, SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal macrophages.Journal of Biological Chemistry,264, 17213–17222.

    PubMed  Google Scholar 

  14. Cooper TW, Bauer EA and Eisen AZ, 1983, Enzyme-linked immunosorbent assay for human skin collagenase.Collagen Related Research,3, 205–216.

    Google Scholar 

  15. Yoshioka H, Oyomada I and Usuko G, 1987, An assay of collagenase activity using enzyme-linked immunosorbent assay for mammalian collagenase.Analytical Biochemistry,166, 172–177.

    PubMed  Google Scholar 

  16. Harris ED and Krane SM, 1972, Endopeptidase from rheumatoid synovial tissue culture.Biochimica et Biophysica Acta,258, 566–576.

    PubMed  Google Scholar 

  17. Sopata I and Dancewicz AW, 1974, Presence of a gelatin-specific proteinase and its latent form in human granulocytes.Biochimica et Biophysica Acta,370, 510–523.

    PubMed  Google Scholar 

  18. Heussen C and Dowdle EB, 1980, Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates.Analytical Biochemistry,102, 196–202.

    PubMed  Google Scholar 

  19. Baylin M, Gomez E, Sinha CC and Thorgeirsson UP, 1988,Ras oncogene mediated induction of a 92 kDa metalloproteinase: Strong correlation with the malignant phenotype.Biochem Biophys Res Commun 154, 832–838.

    PubMed  Google Scholar 

  20. Liotta LA, Tryggavason K, Gabrisa S, Hart I, Foltz CM and Shafie S, 1980, Metastatic potential correlates with enzymatic degradation of basement membrane collagen.Nature,284, 67–68.

    PubMed  Google Scholar 

  21. Seltzer JL, Adams SA, Grant GA and Eisen AZ, 1981, Purification and properties of gelatin-specific neutral proteases from human skin.Journal of Biological Chemistry,256, 4662–4668.

    PubMed  Google Scholar 

  22. Murphy G, McAlpine CG, Poll CT and Reynolds JJ, 1985, Purification and characterization of bone metalloproteinase that degrades gelatin and types IV and V collagen.Biochimica et Biophysica Acta,831, 49–58.

    PubMed  Google Scholar 

  23. Lefebvre V and Vaes G, 1989, The enzymatic evaluation of procollagenase and collagenase inhibitors in crude biologic media.Biochimica et Biophysica Acta,992, 355–361.

    PubMed  Google Scholar 

  24. Zucker S, Lysik RM, Gurfunkel M, Zarrabi MH, Stetler-Stevenson W, Liotta LA, Birkedal-Hansen H and Mann W, 1992, Immunoassay of type IV collagenase/gelatinase (MMP-2) in human plasma.Journal of Immunologic Methods,148, 189–198.

    Google Scholar 

  25. Bergmann U, Michaelis J, Oberhoff R, Knauper V, Beckmann R and Tschesche H, 1989, Enzyme linked immunosorbent assay (ELISA) for the quantitative determination of human leukocyte collagenase and gelatinase.Journal of Clinical Chemistry and Clinical Biochemistry,27, 351–359.

    Google Scholar 

  26. Zucker S, Lysik RM, Zarrabi MH and Moll U, 1993, 92 kDa type IV collagenase is increased in plasma of patients with colon cancer and breast cancer.Cancer Research,53, 140–146.

    PubMed  Google Scholar 

  27. Garbisa S, Scagliotti G, Masiero L, Di Francesco C, Caenazzo C, Onisto M, Micela M, Stetler-Stevenson WG and Liotta LA, 1992, Correlation of serum metalloproteinase levels with lung cancer metastasis and response to therapy.Cancer Research,52, 4548–4549.

    PubMed  Google Scholar 

  28. Birkedal-Hansen B, Moore WGI, Taylor RE, Bhown AS and Birkedal-Hansen H, 1988, Monoclonal antibodies to human fibroblast procollagenase. Inhibition of enzymatic activity, affinity purification of the enzyme, and evidence for clustering of epitopes in the NH2-terminal end of the activated enzyme.Biochemistry,27, 6751–6758.

    PubMed  Google Scholar 

  29. Moll UM, Youngleib GL, Rosinsky KB and Quigley JP, 1990, Tumor promotor-stimulated Mr 92,000 gelatinase secreted by normal and malignant human cells: Isolation and characterization of the enzyme from HT1080 tumor cells.Cancer Research,50, 6162–6170.

    PubMed  Google Scholar 

  30. Moutsiakis D, Mancuso P, Krutzsch H, Stetler-Stevenson W and Zucker S, 1992, Characterization of metalloproteinases and tissue inhibitors of metalloproteinases in human plasma.Journal of Connective Tissue Research,28, 213–230.

    Google Scholar 

  31. Zucker S, Lysik RM, Weiman J, Wilkie DP and Lane B, 1985, Diversity of human cancer cell proteinases: Role of cell membrane metalloproteinases in collagenolysis and cytolysis.Cancer Research,245, 6168–6178.

    Google Scholar 

  32. Murphy G, Willenbrook F, Ward R, Cockett MJ, Eaton D and Docherty AJ, 1992, The C-terminal domain of 72 kDa gelatinase A is not required for catalysis, but is essential for membrane activation and modulates interactions with tissue inhibitors of metalloproteinases.Biochem J,283, 637–641.

    PubMed  Google Scholar 

  33. Kjeldsen L, Bjerrum OW, Hovgaard D, Johnsen AH, Sehested M and Borregaard N, 1992, A marker for circulating neutrophils. Purification and quantitation by enzyme linked immunosorbent assay.European Journal of Haematology,49, 180–191.

    PubMed  Google Scholar 

  34. Rajabi M, Dean DD and Woessner JF, Jr, 1987, High levels of serum collagenase in premature labor: A potential biochemical marker.Obstetrics and Gynecology,69, 179–186.

    PubMed  Google Scholar 

  35. Hendrix MJC, Wood WC, Seftor EA, Lotan D, Nakajima M, Misiorowski RL, Seftor REB, Stetler-Stevenson WG, Bevacqua SJ, Liotta LA, Sobel ME, Raz A and Lotan R, 1990, Retinoic acid inhibition of human melanoma cell invasion through a reconstituted basement membrane and its relation to decreases in the expression of proteolytic enzymes and motility factor receptor.Cancer Research,50, 4121–4130.

    PubMed  Google Scholar 

  36. Masure S, Billiau A, Van Damme J and Opdenakker G, 1990, Human hepatoma cells produce an 85 kDa gelatinase regulated by phorbol 12 myristate 13 acetate.Biochimica et Biophysica Acta,1054, 317–325.

    PubMed  Google Scholar 

  37. Lefebvre V, Peeters-Joris C and Vaes G, 1991, Production of gelatin-degrading matrix metalloproteinases (type IV collagenases) and inhibitors by articular chondrocytes during their dedifferentiation by serial subcultures and under stimulation by interleukin-1 and tumor necrosis factorα. Biochimica et Biophysica Acta,1094, 8–18.

    PubMed  Google Scholar 

  38. Mookhtiar KA, Mallya SK and Van Wart HE, 1986, Properties of radiolabeled type I, II, and III collagens related to their use as substrates in collagenase assays.Analytical Biochemistry,158, 322–333.

    PubMed  Google Scholar 

  39. Teng YT, Sodek J and McCulloch AG, 1992, Gingival crevicular fluid gelatinases and its relationship to periodontal disease in human subjects.Journal of Periodontal Research,27, 544–552.

    PubMed  Google Scholar 

  40. Matrisian LM and Bowden Y, 1990, Stromelysin/ transin and tumor progression.Seminars in Cancer Biology,1, 107–115.

    PubMed  Google Scholar 

  41. Cooksley S, Hipkiss JP, Tickle JP, Holmes-Levers E, Docherty AJ, Murphy G and Lawson AD, 1990, Immunoassays for the detection of human collagenase, stromelysin, tissue inhibitor of metallo proteinases, (TIMP) and enzyme-inhibitor complexes.Matrix,10, 285–291.

    PubMed  Google Scholar 

  42. Zucker S, Lysik RM, Malik M, Bauer BA, Caamano BJ and Klein-Szanto JP, 1992, Secretion of gelatinases and tissue inhibitors of metalloproteinases by human lung cancer cell lines and revertant cell lines: not an invariant correlation with metastasis.International Journal of Cancer,52, 366–371.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zucker, S., Mancuso, P., DiMassimo, B. et al. Comparison of techniques for measurement of gelatinases/type IV collagenases: enzyme-linked immunoassays versus substrate degradation assays. Clin Exp Metast 12, 13–23 (1994). https://doi.org/10.1007/BF01784329

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01784329

Keywords

Navigation